Novo Nordisk (Brazil) Today
| N1VO34 Stock | BRL 82.48 1.78 2.21% |
Performance13 of 100
| Odds Of DistressLess than 9
|
Novo Nordisk is trading at 82.48 as of the 24th of April 2024, a 2.21 percent up since the beginning of the trading day. The stock's open price was 80.7. Novo Nordisk has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Novo Nordisk AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Moving against Novo Stock
| 0.75 | CTXT11 | Fundo Invest Imobiliario | PairCorr |
| 0.7 | VRTX34 | Vertex Pharmaceuticals | PairCorr |
| 0.61 | B1NT34 | BIONTECH SE DRN | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Novo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Novo Nordisk's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Novo Nordisk or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Pres | Lars Jorgensen |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Novo Nordisk AS (N1VO34) is traded on Sao Paulo Exchange in Brazil and employs 54,393 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.67 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novo Nordisk's market, we take the total number of its shares issued and multiply it by Novo Nordisk's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Novo Nordisk AS operates under Healthcare sector and is part of Biotechnology industry. The entity has 2.25 B outstanding shares.
Novo Nordisk generates positive cash flow from operations, but has no cash available
Check Novo Nordisk Probability Of Bankruptcy
Novo Stock Price Odds Analysis
What are Novo Nordisk's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Novo Nordisk jumping above the current price in 90 days from now is about 15.99%. The Novo Nordisk AS probability density function shows the probability of Novo Nordisk stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Novo Nordisk has a beta of 0.5478. This indicates as returns on the market go up, Novo Nordisk average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Novo Nordisk AS will be expected to be much smaller as well. Additionally, novo Nordisk AS has an alpha of 0.3204, implying that it can generate a 0.32 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Novo Nordisk to move above the current price in 90 days from now is about 15.99 (This Novo Nordisk AS probability density function shows the probability of Novo Stock to fall within a particular range of prices over 90 days) .
Novo Nordisk AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Novo Nordisk market risk premium is the additional return an investor will receive from holding Novo Nordisk long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novo Nordisk. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Novo Nordisk's alpha and beta are two of the key measurements used to evaluate Novo Nordisk's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.8 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.49 |
Novo Stock Against Markets
Picking the right benchmark for Novo Nordisk stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Novo Nordisk stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Novo Nordisk is critical whether you are bullish or bearish towards Novo Nordisk AS at a given time. Please also check how Novo Nordisk's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Novo Nordisk without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Novo Nordisk Corporate Management
Elected by the shareholders, the Novo Nordisk's board of directors comprises two types of representatives: Novo Nordisk inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novo. The board's role is to monitor Novo Nordisk's management team and ensure that shareholders' interests are well served. Novo Nordisk's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novo Nordisk's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marcus Schindler | Head EVP | Profile | |
| Monique Carter | Head VP | Profile | |
| Maziar Doustdar | Head VP | Profile | |
| Henrik Wulff | Head VP | Profile | |
| Ludovic Helfgott | Head VP | Profile |
How to buy Novo Stock?
Before investing in Novo Nordisk, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Novo Nordisk. To buy Novo Nordisk stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Novo Nordisk. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Novo Nordisk stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Novo Nordisk AS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Novo Nordisk AS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Novo Nordisk AS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Novo Stock please use our How to Invest in Novo Nordisk guide.
Already Invested in Novo Nordisk AS?
The danger of trading Novo Nordisk AS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Novo Nordisk is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Novo Nordisk. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Novo Nordisk AS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Novo Nordisk AS information on this page should be used as a complementary analysis to other Novo Nordisk's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |